ArticleMedical physics2020
An investigation into the robustness of dynamically collimated proton therapy treatments.
Article in Medical physics, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
10 citing papers in PubMed, 12 citations in OpenAlex.
- Evaluations of Penumbra Reduction Using Multi-Leaf Collimator and 3D Bolus in Scanned Proton Therapy.International journal of particle therapy · 2026Article
- Integration and dosimetric validation of a dynamic collimation system for pencil beam scanning proton therapy.Biomedical physics & engineering express · 2023Article
- Design, testing and characterization of a proton central axis alignment device for the dynamic collimation system.Biomedical physics & engineering express · 2023Article
- Mechanical Characterization and Validation of the Dynamic Collimation System Prototype for Proton Radiotherapy.Journal of medical devices · 2022Article
- The dosimetric enhancement of GRID profiles using an external collimator in pencil beam scanning proton therapy.Medical physics · 2022Article
- Investigating aperture-based approximations to model a focused dynamic collimation system for pencil beam scanning proton therapy.Biomedical physics & engineering express · 2022Article
- Proton therapy needs further technological development to fulfill the promise of becoming a superior treatment modality (compared to photon therapy).Journal of applied clinical medical physics · 2021Article
- Development and validation of the Dynamic Collimation Monte Carlo simulation package for pencil beam scanning proton therapy.Medical physics · 2021Article
- Innovations and the Use of Collimators in the Delivery of Pencil Beam Scanning Proton Therapy.International journal of particle therapy · 2021Article
- Experimental and Monte Carlo characterization of a dynamic collimation system prototype for pencil beam scanning proton therapy.Medical physics · 2020Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 2 institutions in 1 country.
Funding
Abstract
purposeTo investigate the dosimetric robustness of dynamically collimated proton therapy (DCPT) treatment plans delivered using a dynamic collimation system (DCS) with respect to random uncertainties in beam spot and collimator position as well as systematic offsets in the DCS mounting alignment. This work also demonstrates a technique that can increase plan robustness while preserving target conformity.
methodsVariability in beam spot and collimator positioning can result in changes to a beamlet's dose distribution and incident fluence. The robustness of the DCPT treatment plans was evaluated for three intracranial treatment sites by modeling treatment variability as normally distributed random variables with standard deviations reflecting a clinical system. The simulated treatment plans were then recalculated and compared against their nominal, idealized dose distribution among several trials. It was hypothesized that a plan's robustness to these delivery variables could be reduced by restricting a trimmer's placement toward a beamlet's central axis during collimation.
resultsBy introducing a minimum trimmer offset of 1.5 mm, the variation of the planning target volume (PTV) D
conclusionsWhile DCPT can offer a significant reduction in healthy tissue irradiation, the results from this work indicate that special care must be taken to ensure proper PTV coverage amid uncertainties associated with this new treatment modality. A simple approach utilizing a minimum trimmer offset was able to preserve the majority of the target conformity and healthy tissue sparing the DCS technology affords while minimizing the uncertainties in this treatment approach.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.